| ADJUSTED EARNINGS PER SHARE EXCLUDING SPECIAL ITEM | Income Before
Income Taxes | Income Tax Expense | Net Income | Earnings Per
Diluted Share* | |||||||||
| Nine Months Ended March 31, 2023, as reported | $ | 23.9 | $ | (5.9 | ) | $ | 18.0 | $ | 0.36 | ||||
| Special item: | |||||||||||||
| None reported | — | — | — | — | |||||||||
| Nine Months Ended March 31, 2023, as adjusted | $ | 23.9 | $ | (5.9 | ) | $ | 18.0 | $ | 0.36 | ||||
| * Impact per diluted share calculated using weighted average common shares outstanding of 49.0 million for the nine months ended March 31, 2023. | |||||||||||||
| ADJUSTED LOSS PER SHARE EXCLUDING SPECIAL ITEMS | Loss Before
Income Taxes | Income Tax Benefit | Net Loss | Loss Per
Diluted Share* | ||||||||||||
| Nine Months Ended March 31, 2022, as reported | $ | (68.5 | ) | $ | 16.8 | $ | (51.7 | ) | $ | (1.07 | ) | |||||
| Special items: | ||||||||||||||||
| COVID-19 costs | 5.3 | (1.3 | ) | 4.0 | 0.08 | |||||||||||
| Acquisition-related contingent liability release | (4.7 | ) | 1.1 | (3.6 | ) | (0.07 | ) | |||||||||
| Nine Months Ended March 31, 2022, as adjusted | $ | (67.9 | ) | $ | 16.6 | $ | (51.3 | ) | $ | (1.06 | ) | |||||
| * Impact per diluted share calculated using weighted average common shares outstanding of 48.5 million for the nine months ended March 31, 2022. | ||||||||||||||||
